ASMS 2026 Press Conference
Pioneering 4D Multiomics and Functional Proteomics 2.0
Bruker today announces new developments in its market-leading mass spectrometry portfolio, highlighting advances designed to accelerate scientific discovery across multiple application areas.
Supporting materials for the ASMS press conference, including press releases and marketing assets, are available below. These cover the latest innovations spanning proteomics, metabolomics, imaging, and pharma/biopharma workflows, as well as industrial and applied analysis.
Press Release ASMS 2026
Marketing Materials
timsMRMS
timsOmni™
- timsOmni Page
- timsOmni Brochure - An eXtreme leap in deep proteoform sequencing and advanced structural elucidation
- FN 31 - Efficient Protein Characterization with timsOmni and ProSight Native
- FN 32 - Deep Protein Characterization Simplified: SampleStream-timsOmni-ProSight Native
- LCMS 258 - High Confidence Glycopeptide Structural Analysis Using timsOmni
- LCMS 259 - Native Top-Down Mass Spectrometry on the timsOmni Platform Enables Deep Structural Analysis of Protein Complexes
- TN 66 - Definitive Protein Sequencing by Top-Down Mass Spectrometry Using timsOmni and OmniScape
- FN 39 - Multimodal Fragmentation of Cyclic Peptides with timsOmni
timsUltra AIP
- timsUltra AIP Page
- timsUltra AIP Brochure - Redefining sensitivity
- LCMS 256 - Ultra Deep Proteomic Profiling of Synovial Fluid Identifies Osteoarthritis Associated Biomarkers
- LCMS 261 - Label-free and isobaric multiplexing-based single cell proteomics with the BOXmini SCP in scalable workflows on the timsUltra AIP
- LCMS 262 - Scalable spatial proteomics with preserved bio insights using the Evosep Eno standard gradients on the timsUltra AIP
For press inquiries please contact:
Alison Owen
Kapler Communications
E: bdal@kapleronline.com
For Research Use Only. Not for use in clinical diagnostic procedures.